articleCancer CellFeb 15, 2024Closed access

Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

BYBarzin Y. NabetHHHabib HamidiMCMyung Chang LeeRBRomain BanchereauSMStefanie Morris

Genesys (United States) · Roche (Switzerland) · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

150
total citations
FWCI
37.17
Percentile
100%
References
55
Citations per year

Authors

27

Topics & keywords

Topics
Keywords
  • Immunotherapy
  • Immune system
  • Immune checkpoint
  • Blockade
  • Etoposide
  • Atezolizumab
  • Effector
  • Immunology
UN Sustainable Development Goals
  • Reduced inequalities
No related works found for this paper.

Funding